PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily.

PubWeight™: 5.28‹?› | Rank: Top 1%

🔗 View Article (PMID 1690453)

Published in Science on March 09, 1990

Authors

P J Newman1, M C Berndt, J Gorski, G C White, S Lyman, C Paddock, W A Muller

Author Affiliations

1: The Blood Center of Southeastern Wisconsin, Milwaukee 53233.

Articles citing this

(truncated to the top 100)

PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med (1993) 4.81

Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol (1991) 3.91

The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature (2009) 3.88

A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol (1992) 3.85

Organization of immunological memory by bone marrow stroma. Nat Rev Immunol (2010) 3.57

Cellular levels of p120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells. J Cell Biol (2003) 3.39

The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol (1995) 3.27

Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol (2006) 2.57

Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest (2002) 2.50

CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J Exp Med (1992) 2.38

Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci U S A (1995) 2.37

A cell culture model of the blood-brain barrier. J Cell Biol (1991) 2.35

Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth. J Exp Med (2012) 2.21

Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol (1997) 2.17

Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med (1994) 2.16

Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment. Am J Pathol (2003) 2.12

Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep (2012) 2.06

Evidence for a role of platelet endothelial cell adhesion molecule-1 in endothelial cell mechanosignal transduction: is it a mechanoresponsive molecule? J Cell Biol (2002) 2.03

The biology of PECAM-1. J Clin Invest (1997) 2.01

CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol (1995) 1.93

Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J Exp Med (2009) 1.93

Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. J Am Coll Cardiol (2010) 1.92

Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol (1996) 1.90

The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol (1991) 1.85

Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci U S A (2001) 1.84

Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med (1995) 1.81

Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1α. Cancer Res (2011) 1.75

Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg (2004) 1.72

Monocyte-selective transendothelial migration: dissection of the binding and transmigration phases by an in vitro assay. J Exp Med (1992) 1.72

Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol (1994) 1.70

Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am J Pathol (2005) 1.65

Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer (1998) 1.64

Regulation of lymph node vascular growth by dendritic cells. J Exp Med (2006) 1.62

The shear stress of it all: the cell membrane and mechanochemical transduction. Philos Trans R Soc Lond B Biol Sci (2007) 1.61

Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med (1997) 1.60

Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells (2005) 1.58

A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J Exp Med (1992) 1.55

Platelet PECAM-1 inhibits thrombus formation in vivo. Blood (2005) 1.53

The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol (1994) 1.52

Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol (1992) 1.48

Switched at birth: a new family for PECAM-1. J Clin Invest (1999) 1.47

Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. Circ Res (2011) 1.45

Leukocyte transmigration requires kinesin-mediated microtubule-dependent membrane trafficking from the lateral border recycling compartment. J Exp Med (2008) 1.43

Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. J Clin Invest (1993) 1.42

Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts. J Cell Biol (1995) 1.38

The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding. Mol Cell Biol (1995) 1.36

The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol (2012) 1.35

Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution. J Cell Biol (1992) 1.34

Endothelial signaling in paracellular and transcellular leukocyte transmigration. Front Biosci (Landmark Ed) (2009) 1.31

Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation. Am J Pathol (1992) 1.30

PECAM-1: conflicts of interest in inflammation. Life Sci (2010) 1.30

HOXA13 Is essential for placental vascular patterning and labyrinth endothelial specification. PLoS Genet (2008) 1.25

Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1. Proc Natl Acad Sci U S A (1993) 1.25

Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule 1. Proc Natl Acad Sci U S A (1996) 1.25

Identification of a Ca2(+)-dependent cell-cell adhesion molecule in endothelial cells. J Cell Biol (1990) 1.24

Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties. J Cell Biol (1994) 1.23

Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology (1993) 1.22

Identification of Fer tyrosine kinase localized on microtubules as a platelet endothelial cell adhesion molecule-1 phosphorylating kinase in vascular endothelial cells. Mol Biol Cell (2003) 1.19

Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases. Proc Natl Acad Sci U S A (2013) 1.17

Wound healing and blastema formation in regenerating digit tips of adult mice. Dev Biol (2010) 1.17

Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling. J Biol Chem (2010) 1.16

Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol (2003) 1.16

Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific. J Physiol (2006) 1.15

TCR stimulation drives cleavage and shedding of the ITIM receptor CD31. J Immunol (2010) 1.15

RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1. Blood (2008) 1.13

Expression of cell-cell and cell-matrix adhesion proteins by sinusoidal endothelial cells in the normal and cirrhotic human liver. Am J Pathol (1993) 1.13

Future innovations in anti-platelet therapies. Br J Pharmacol (2008) 1.13

Examining the technique of angiogenesis assessment in invasive breast cancer. Br J Cancer (1997) 1.12

Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues. J Cell Biol (1991) 1.11

PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation. Am J Pathol (2006) 1.11

p75(NTR) mediates neurotrophin-induced apoptosis of vascular smooth muscle cells. Am J Pathol (2000) 1.10

Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. Am J Pathol (1993) 1.08

Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. Am J Pathol (1997) 1.07

Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. J Clin Pathol (2005) 1.06

Thrombospondin-1, a natural inhibitor of angiogenesis, regulates platelet-endothelial cell adhesion molecule-1 expression and endothelial cell morphogenesis. Mol Biol Cell (1997) 1.06

Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes. J Control Release (2008) 1.06

PECAM-1: regulator of endothelial junctional integrity. Cell Tissue Res (2014) 1.05

Identification of the binding site in intercellular adhesion molecule 1 for its receptor, leukocyte function-associated antigen 1. Mol Biol Cell (1997) 1.05

PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis. Mol Biol Cell (2000) 1.04

Expression and cell distribution of the intercellular adhesion molecule, vascular cell adhesion molecule, endothelial leukocyte adhesion molecule, and endothelial cell adhesion molecule (CD31) in reactive human lymph nodes and in Hodgkin's disease. Am J Pathol (1992) 1.04

Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype. Mol Biol Cell (1998) 1.03

Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis. World J Gastroenterol (2013) 1.03

Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo. J Clin Invest (2014) 1.03

Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses. J Exp Med (1996) 1.01

Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family. Immunology (1992) 1.01

A novel and critical role for tyrosine 663 in platelet endothelial cell adhesion molecule-1 trafficking and transendothelial migration. J Immunol (2009) 1.00

The alleles of PECAM-1. Gene (2006) 1.00

Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J Leukoc Biol (2006) 0.99

Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. Am J Pathol (1997) 0.99

EA-1, a novel adhesion molecule involved in the homing of progenitor T lymphocytes to the thymus. J Cell Biol (1991) 0.99

Collaborative enhancement of antibody binding to distinct PECAM-1 epitopes modulates endothelial targeting. PLoS One (2012) 0.98

Ligand bridging mediates integrin alpha IIb beta 3 (platelet GPIIB-IIIA) dependent homotypic and heterotypic cell-cell interactions. J Clin Invest (1991) 0.98

Clnk, a novel SLP-76-related adaptor molecule expressed in cytokine-stimulated hemopoietic cells. J Exp Med (1999) 0.98

Neutrophil and monocyte recruitment by PECAM, CD99, and other molecules via the LBRC. Semin Immunopathol (2013) 0.97

Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease. Clin Exp Immunol (1993) 0.97

Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS One (2010) 0.96

Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity. J Cell Sci (2011) 0.96

Residues within a lipid-associated segment of the PECAM-1 cytoplasmic domain are susceptible to inducible, sequential phosphorylation. Blood (2011) 0.95

CD34 immunoreactivity in nervous system tumors. Acta Neuropathol (1994) 0.95

Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy. Front Endocrinol (Lausanne) (2013) 0.94

Articles by these authors

Endocytosis and the recycling of plasma membrane. J Cell Biol (1983) 10.24

Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity (1999) 5.23

Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science (1998) 4.97

A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. Proc Natl Acad Sci U S A (1966) 4.73

Influenza seasonality: underlying causes and modeling theories. J Virol (2006) 4.22

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med (1989) 4.04

Stereospecific binding of estrogens in the rat uterus. Arch Biochem Biophys (1965) 3.93

Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol (1991) 3.91

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int (2008) 3.80

Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes. EMBO J (1983) 3.36

Occupations of fathers of children dying from neoplasms. J Epidemiol Community Health (1981) 3.25

Current models of steroid hormone action: a critique. Annu Rev Physiol (1976) 2.78

The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell (2000) 2.76

A receptor molecule for estrogens: studies using a cell-free system. Proc Natl Acad Sci U S A (1967) 2.70

The membrane proteins of the vacuolar system. II. Bidirectional flow between secondary lysosomes and plasma membrane. J Cell Biol (1980) 2.69

PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Nat Med (1997) 2.64

Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol (1999) 2.55

The membrane proteins of the vacuolar system I. Analysis of a novel method of intralysosomal iodination. J Cell Biol (1980) 2.48

Nuclear localization of unoccupied oestrogen receptors. Nature (1984) 2.33

Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med (2000) 2.31

Bernard-Soulier syndrome. Blood (1998) 2.29

Hormone receptors: studies on the interaction of estrogen with the uterus. Recent Prog Horm Res (1968) 2.28

Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med (1994) 2.16

Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood (2001) 2.00

HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet (1997) 1.95

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. Lancet (1997) 1.94

A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc Natl Acad Sci U S A (1987) 1.87

Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med (1995) 1.81

Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines. J Immunol (1987) 1.77

SH2- and SH3-mediated interactions between focal adhesion kinase and Src. J Biol Chem (1998) 1.77

The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med (1999) 1.76

Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII. J Thromb Haemost (2003) 1.74

Polymorphism near the rat prolactin gene caused by insertion of an Alu-like element. Nature (1983) 1.72

The separation and identification of alpha- and beta-globin messenger ribonucleic acids. J Biol Chem (1974) 1.72

Size heterogeneity of polyadenylate sequences in mouse globin messenger RNA. J Mol Biol (1974) 1.71

Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J Virol (1998) 1.69

Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18). J Immunol (1995) 1.69

Estrogen action in vitro. Induction of the synthesis of a specific uterine protein. J Biol Chem (1972) 1.66

Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest (1988) 1.63

GMP-140 binding to neutrophils is inhibited by sulfated glycans. J Biol Chem (1991) 1.62

A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc Natl Acad Sci U S A (1998) 1.62

Superior mesenteric vein thrombosis with radiologically occult cause: a retrospective study of 43 cases. AJR Am J Roentgenol (2001) 1.61

Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med (1997) 1.60

Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia (2007) 1.57

Cell-free synthesis of a large translation product of prolactin messenger RNA. J Biol Chem (1976) 1.57

Polymorphism of human Ia antigens: gene conversion between two DR beta loci results in a new HLA-D/DR specificity. Nature (1986) 1.57

Estrogen-induced synthesis of a specific uterine protein. Proc Natl Acad Sci U S A (1966) 1.55

Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. J Biol Chem (1993) 1.55

Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow. J Cell Biol (2000) 1.55

Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140. Science (1990) 1.54

Membrane proteins of the vacuolar system. III. Further studies on the composition and recycling of endocytic vacuole membrane in cultured macrophages. J Cell Biol (1983) 1.52

Molecular organization of the HLA-SB region of the human major histocompatibility complex and evidence for two SB beta-chain genes. Proc Natl Acad Sci U S A (1984) 1.51

Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation. J Immunol (1996) 1.51

Estrogen receptor and progesterone receptor genes are expressed differentially in mouse embryos during preimplantation development. Proc Natl Acad Sci U S A (1993) 1.50

Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem (1996) 1.50

PETA-3/CD151, a member of the transmembrane 4 superfamily, is localised to the plasma membrane and endocytic system of endothelial cells, associates with multiple integrins and modulates cell function. J Cell Sci (1999) 1.47

Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol (1997) 1.46

Plasmalemmal proteins of cultured vascular endothelial cells exhibit apical-basal polarity: analysis by surface-selective iodination. J Cell Biol (1986) 1.44

Issues with the assay of factor VIII activity in plasma and factor VIII concentrates. Thromb Haemost (2000) 1.44

The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J Biol Chem (1999) 1.44

Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. Diabetologia (2008) 1.43

A class I MHC-restricted recall response to a viral peptide is highly polyclonal despite stringent CDR3 selection: implications for establishing memory T cell repertoires in "real-world" conditions. J Immunol (1998) 1.43

Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease. J Thromb Haemost (2008) 1.42

Estrogen receptors in the rat uterus. Studies on the interaction of cytosol and nuclear binding sites. J Biol Chem (1969) 1.42

Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost (2007) 1.41

Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane. Eur J Biochem (1985) 1.40

PCB intake and the growth of waterfowl: multivariate analyses based on a reparameterized Richards sigmoid model. Growth (1986) 1.40

The partial thromboplastin time. J Thromb Haemost (2014) 1.39

Glycoprotein Ib-IX-V. Int J Biochem Cell Biol (2003) 1.38

Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells (1998) 1.37

Evaluating the effects of endocrine disruptors on endocrine function during development. Environ Health Perspect (1999) 1.36

Identification of a novel integrin beta subunit expressed on cultured monocytes (macrophages). Evidence that one alpha subunit can associate with multiple beta subunits. J Biol Chem (1990) 1.36

Characterization of high-risk HIV-1 seronegative hemophiliacs. Clin Immunol (2001) 1.35

Structure of the glycoprotein Ib.IX complex from platelet membranes. J Biol Chem (1988) 1.35

Hormone-substrate interrelationships following trauma. Arch Surg (1974) 1.34

Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution. J Cell Biol (1992) 1.34

Extrogen control of uterine glucose metabolism. An analysis based on the transport and phosphorylation of 2-deoxyglucose. J Biol Chem (1968) 1.34

Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol (1993) 1.34

Partial amino acid sequence of rat pre-prolactin. Biochem J (1977) 1.34

Functional differences in lipid metabolism in resting skeletal muscle of various fiber types. Am J Physiol (1997) 1.31

Molecular analysis of T cell repertoires. Spectratypes generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence. Hum Immunol (1995) 1.31

A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology (1981) 1.30

Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment. J Immunol (2000) 1.29

Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3) using a reconstituted mammalian cell expression model. J Cell Biol (1999) 1.29

The genomic organization of platelet glycoprotein IIIa. J Biol Chem (1990) 1.29

P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J Biol Chem (1995) 1.29

Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med (1992) 1.28

Role of RNA synthesis in the estrogen induction of a specific uterine protein. Proc Natl Acad Sci U S A (1970) 1.28

Adhesion protein GMP140 inhibits superoxide anion release by human neutrophils. Proc Natl Acad Sci U S A (1991) 1.28

Role of Fc receptor gamma-chain in platelet glycoprotein Ib-mediated signaling. Blood (2001) 1.28

PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis. Immunity (1999) 1.27

Identification of a membrane skeleton in platelets. J Cell Biol (1988) 1.25

Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1. Proc Natl Acad Sci U S A (1993) 1.25

n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia (2009) 1.25

Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V. J Biol Chem (1981) 1.24

Reliability of lower extremity alignment measurement using radiographs and PACS. Knee Surg Sports Traumatol Arthrosc (2011) 1.24

Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex. Blood (2000) 1.24

Probable nuclear precursors of preprolactin mRNA in rat pituitary cells. J Biol Chem (1981) 1.24